v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Operating activities:    
Net income $ 1,649.2 $ 1,367.9
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and loss on disposal of property, plant, and equipment 371.2 289.6
Amortization of intangible and other assets 59.9 24.4
Accretion of discounts, amortization of premiums, and (gains) losses on investments, net (19.0) (27.4)
Gain on sale of business and assets 7.9 0.0
Deferred income taxes 370.3 (29.4)
Share-based compensation expense 419.4 381.4
Changes in operating assets and liabilities, net of effects of acquisitions:    
Accounts receivable (49.8) (44.1)
Inventory (514.6) (494.2)
Prepaids and other assets (179.0) (141.8)
Accounts payable 21.4 72.4
Accrued compensation and employee benefits (229.7) (114.9)
Deferred revenue 44.7 48.8
Other liabilities 36.8 (35.7)
Net cash provided by operating activities 1,972.9 1,297.0
Investing activities:    
Purchase of investments (1,349.1) (691.8)
Proceeds from sales of investments 0.1 249.1
Proceeds from maturities of investments 1,106.0 1,190.0
Proceeds from sale of assets 46.0 0.0
Purchase of property, plant, and equipment (215.9) (271.9)
Acquisition of business, net of cash, and intellectual property and other investing activities (528.2) (1.2)
Net cash provided by (used in) investing activities (941.1) 474.2
Financing activities:    
Proceeds from issuance of common stock relating to employee stock plans 187.4 183.7
Taxes paid related to net share settlement of equity awards (365.4) (386.3)
Repurchase of common stock (1,443.5) (181.0)
Other financing activities (20.1) 0.0
Net cash used in financing activities (1,641.6) (383.6)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash 8.1 (3.5)
Net increase (decrease) in cash, cash equivalents, and restricted cash (601.7) 1,384.1
Cash, cash equivalents, and restricted cash, beginning of period 3,407.4 2,062.4
Cash, cash equivalents, and restricted cash, end of period 2,805.7 3,446.5
Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]    
Acquisition of property, plant, and equipment in accounts payable and accrued liabilities 68.8 74.8
Unsettled common stock repurchases in accrued liabilities $ 63.5 $ 0.0